Dr. Hönle AG

EANS-News: Hönle Group reports further improvement in the operating result in the first six months

@@start.t1@@--------------------------------------------------------------------------------   Corporate news transmitted by euro adhoc. The issuer/originator is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

quarterly report

Gräfeling/München (euro adhoc) - Hönle Group continued to improve its operating result in the first six months of the 2009/2010 financial year. The operating result (EBIT) soared from TEUR -2,180 in the previous year to TEUR 2,098 in the first six months of the current financial year, while sales revenues were up 11.0 % to TEUR 25,056. Earnings before tax (EBT) rose from TEUR -2,204 to TEUR 1,981, while the consolidated result increased from TEUR -1,686 to TEUR 1,282. Earnings per share climbed from EUR -0.33 to EUR 0.22. The operating cash flow improved from TEUR -2,159 in the previous year to TEUR 1,439 in the first six months of the current financial year.

Outlook: The rebound in demand is continuing at the Hönle Group. Incoming orders and existing orders at the end of the six months of the current financial year are significantly above the levels reported in the previous year. Dr. Hönle AG´s Management Board expects the third quarter to be the strongest with respect to sales revenues and operating result since the beginning of the current financial year. Hönle continues to adhere to its announced annual targets, which comprise expected sales revenues ranging from EUR 47 to EUR 50 million, while the operating result is expected to come in at EUR 3 to EUR 4 million.

With a view to handling future growth, Dr. Hönle AG rented another company building in Gräfelfing near Munich. Nevertheless, rental expenses will remain unchanged as a result of the renegotiation of already existing rental agreements. Small investments in the acquisition of a machine for improving production efficiency are planned for the current quarter. Moreover, the establishing of strategic, centralised procurement will lead to cost reductions. New staff will be hired for the sales team at Eltosch GmbH in Hamburg. The objective is to increase the company´s sale of services and spares parts in addition to the sale of systems. A trading company will be established in Shanghai with a view to the further tapping of the Asian adhesives market. The Panacol Group thus continues the dynamic expansion of the distribution network in South-East Asia, in particular. Additionally, Panacol will continue to invest in the development of new adhesives and drive the development of intelligent adhesives, as an example. To this end, Panacol will also hire new R&D staff.

As a result of the acquisition of three companies or groups in 2008, the Hönle Group became the second largest systems supplier for industrial UV technology worldwide. The subsequent restructuring in 2009 led to a significant reduction in the break-even threshold. Hönle has now laid the basis for achieving much higher sales revenues and operating results than those achieved in the past.

About Hönle: Dr. Hönle AG is a listed technology company with registered head office in Gräfelfing, near Munich. With a staff level of ca. 250 employees, the Hönle Group is one of the world´s leading systems suppliers in the UV technology segment. The equipment and systems are used for drying inks and coatings, curing adhesives and plastics, disinfecting surfaces, and in the simulation of natural sunlight. The Company´s business activities focus also on the development and sale of industrial adhesives and compounds. The Group is represented worldwide at 50 locations in more than 20 countries by own companies and sales partners.

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: Dr. Hönle AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Peter Weinert
Tel.: +49 89 85608 173
E-Mail: peter.weinert@hoenle.de

Branche: Instrument Engineering
ISIN:      DE0005157101
WKN:        515710
Index:    CDAX, Prime All Share, Technology All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              Hannover / free trade
              München / free trade

Weitere Meldungen: Dr. Hönle AG

Das könnte Sie auch interessieren: